期刊文献+

HLA衍生肽RDP1258延长大鼠移植心脏存活时间 被引量:2

Effect of RDP1258 on survival of rat cardiac allograft
原文传递
导出
摘要 目的 观察HLA衍生肽RDP1258对大鼠同种移植心脏存活时间的影响。方法人工合成HLA衍生肽RDP1258;建立大鼠心脏腹部移植模型,随机分为4组。(1)对照组:心脏移植前后不用任何药物;(2)环孢素A(CsA)组:心脏移植前后给予CsA灌胃;(3)RDP1258组:心脏移植前后给予PDP1258腹腔注射;(4)RDP1258+CsA组:心脏移植前后联合给予RDP1258和CsA。分别观察人工合成的RDP1258纯度、移植心存活时间及移植心组织的光镜及电镜检查情况。结果RDP1258纯度达95%以上,分子量与理论值相符。大鼠移植心脏存活时间:对照组为(8.00±2.90) d,CsA组为(13.38±3.62)d,RDP1258组为(33.29±10.09)d,RDP1258+CsA组为(85.38±18.34) d。RDP1258组和RDP1258+CsA组与对照组比较,移植心脏存活时间显著延长。RDP1258组和RDP1258+csA组移植心病理改变较轻,超微结构无明显改变。结论RDP1258能抑制急性排斥反应,围手术期给予RDP1258和CsA,能够明显延长大鼠移植心脏存活时间。 Objective To investigate the effects of RDP1258 on survival of rat cardiac allograft. Methods RDP1258 was synthesized and the model of rat heart abdominal transplantation was established. Animals were divided into four groups. Group 1 received no immunosuppression. Group 2 received CsA alone. Group 3 received RDP1258 alone. Group 4 received RDP1258 and subtherapeutic CsA. In all cases RDP1258 was administrated intraperitoneally and CsA was gavaged. Light and electron microscopic examinations were taken . Transplanted hearts were monitored daily by direct palpation. Results The purity of synthesized RDP1258 was over 95 % and the molecular weight was in accord with theoretical value. The histology and the ultrastructure changed little in grafts in group 3 and group 4. Survival of rat cardiac allograft was significantly prolonged in group 4. Conclusions RDP1258 can suppress acute rejection. Perioperative administration of RDP1258 in combination with CsA can significantly prolong survival of rat cardiac allograft.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2005年第4期217-219,共3页 Chinese Journal of Organ Transplantation
基金 国家新药基金资助项目(9690105184)
  • 相关文献

参考文献15

  • 1Frasca L, Tamin A, Jurcevic S, et al. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Transplantation, 2000, 70: 631-637.
  • 2Cristensen LL, Grunnet N, Rudiger N, et al. Indications of immunological tolerance in kidney transplantation. Tissue Antigens, 1998, 51: 632-637.
  • 3Masroor S, Itescu S, Artrip JH, et al. Induction of tolerance in rodent cardiac allotransplantation using an MHC class Ⅰ-derived peptide and cyclosporin A. Ann Thorac Surg, 1998, 65: 144-148.
  • 4Gao L, Woo J, Buelow R, et al. Both L-and D- isomers of HLA class heavy chain derived peptides prolong heart allograft survival in mice. Heart and Lung Transplantation, 1996, 15: 78-87.
  • 5Ono K, Lindsey ES, Orleans N, et al. Improved technique of heart transplantation in the rat. J Thorac Cardiovasc Surg,1969,57: 225-229.
  • 6Sojif O, Nepal C,Rashid F, et al. Induction of doner-specific unresponsiveness to rat cardic allograft by pretreatment with intrathymic donor MHC class Ⅰ antigen. Transplantation, 1993, 55:1396-1401.
  • 7Oluwole SF, Chowdhury NC, Ingram M,et al. Mechanism of acquired thymic tolerance induced by a single major histocompatibility complex class Ⅰ peptide with the dominant epitope diferential analysis of regulatory cytokines in the lymphoid and intragraft compartments. Transplantation, 1999, 68: 418-423.
  • 8Cuturi MC, Josien R, Douillard P, et al. Prolongation of allogeneic heart graft survival in rats by adiministration of a peptide(a.a 75-84) from the α1 helices of the fist domain of HLA-B7.Transplantation, 1995, 59: 661-665.
  • 9Grassy G, Calas B, Yasri A, et al. Computer-assisted rational design of immunosuppressive compounds. Nature Bio Tech,1998, 16: 748-754.
  • 10Cuturi MC, Josien R, Donillard P, et al. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allogtaf survival in rats analysis of its mechanidm of action. Mol Med,1999, 5: 820-828.

同被引文献18

  • 1Fujie T, Tahara K, Tanaka F, et al. A MAGE-1-encoded HLAA24 binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes [J]. Int J Cancer, 1999,80(2) :169-172.
  • 2Manici S, Sturniolo T, Imro MA, et al. Melanoma cells present a MAGE-3 epitope to CD4 (+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11 [J]. J Exp Med, 1999, 189(5) .-871-876.
  • 3Carey B, DeLay M, Strasser JE, et al. A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivo [J]. Clin Immunol, 2005,116(1) ..65 76.
  • 4Shen X, Hu B, McPhie P, et al. Peptides corresponding to CD4-in teracting regions of routine MHC class II molecules modulate im mune responses of CD4^+ T lymphocytes in vitro and in vivo [J] J Immunol, 1996,157(1) :87-100.
  • 5Grassy G,Calas B, Yasri A,et al. Computer-assisted rational design of immunosuppressive compounds [ J ]. Nat Biotechnol, 1998,16(8) :748-752.
  • 6Cuturi MC,Josien R,Douillard P, et al. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a. a. 75- 84) from the alpha 1 helix of the first domain of HLA-B7 01 [J]. Transplantation, 1995,59 (5) : 661-669.
  • 7Cuturi MC, Christoph F, Woo J, et al. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats : analysis of its mechanism of action [J]. Mol Med, 1999,5 (12) :820-832.
  • 8Oluwole SF, Chowdhury NC, Ingram M, et al. Mechanism of acquired thymie tolerance induced by a single major histocompatibility complex class I peptide with the dominant epitope:differential analysis of regulatory cytokines in the lymphoid and intragraft compartments [J]. Transplantation, 1999,68(3) :418-429.
  • 9Gorczynski RM, Chen Z, Kai Y, et al. Induction of toleranceinducing antigen-presenting cells in bone marrow cultures in vitro using monoclonal antibodies to CD200R [ J ]. Transplantation, 2004, 77(8) : 1138 - 1144.
  • 10Liang S, Horuzsko A. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G [ J ]. Hum Immunol, 2003, 64(11): 1025-1032.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部